- Home
- MNTK vs EYPT Comparison
MNTK vs EYPT Comparison
Compare MNTK & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- EYPT
- Stock Information
- Founded
- MNTK 1980
- EYPT 1987
- Country
- MNTK United States
- EYPT United States
- Employees
- MNTK N/A
- EYPT N/A
- Industry
- MNTK Natural Gas Distribution
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- MNTK Utilities
- EYPT Industrials
- Exchange
- MNTK Nasdaq
- EYPT Nasdaq
- Market Cap
- MNTK 622.2M
- EYPT 489.4M
- IPO Year
- MNTK 2021
- EYPT 2005
- Fundamental
- Price
- MNTK $4.22
- EYPT $7.69
- Analyst Decision
- MNTK Hold
- EYPT Strong Buy
- Analyst Count
- MNTK 2
- EYPT 8
- Target Price
- MNTK $6.00
- EYPT $25.71
- AVG Volume (30 Days)
- MNTK 156.6K
- EYPT 665.0K
- Earning Date
- MNTK 03-13-2025
- EYPT 03-06-2025
- Dividend Yield
- MNTK N/A
- EYPT N/A
- EPS Growth
- MNTK 42.11
- EYPT N/A
- EPS
- MNTK 0.16
- EYPT N/A
- Revenue
- MNTK $194,849,000.00
- EYPT $45,713,000.00
- Revenue This Year
- MNTK $21.28
- EYPT N/A
- Revenue Next Year
- MNTK $31.59
- EYPT N/A
- P/E Ratio
- MNTK $26.27
- EYPT N/A
- Revenue Growth
- MNTK 9.63
- EYPT 7.50
- 52 Week Low
- MNTK $3.38
- EYPT $6.90
- 52 Week High
- MNTK $6.88
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- MNTK 47.56
- EYPT 41.66
- Support Level
- MNTK $4.01
- EYPT $7.58
- Resistance Level
- MNTK $4.34
- EYPT $8.16
- Average True Range (ATR)
- MNTK 0.22
- EYPT 0.55
- MACD
- MNTK -0.02
- EYPT -0.07
- Stochastic Oscillator
- MNTK 20.63
- EYPT 3.06
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.